Project Grant R35GM166590
- The National Institute of General Medical Sciences awarded the University of New Mexico $404,464 on August 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational methods for characterizing nucleic acids and DNA nanotechnology toward therapeutic design. The research team at UNM will combine quantum chemistry, molecular dynamics, and machine learning to predict electronic structure properties—electron densities, energies, and forces—of...
- The National Institute of General Medical Sciences awarded the University of New Mexico $370,940 on August 22, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop high-throughput free energy computational methods for small molecule, peptide, and protein design in drug discovery and optimization. The project integrates enhanced sampling methods with multisite lambda dynamics (MSLD) to create MSLD++, a framework intended to overcome computational...
- The National Institute of General Medical Sciences awarded New Mexico Institute of Mining and Technology $148,495 on September 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop and apply an AI-enabled measurement framework evaluating how place-based biomedical policies affect biomedical PhD careers, innovation, and firm-level dynamics. The project pursues three integrated aims. Aim 1 constructs a validated place-by-year database of U.S. state- and...
- The National Institute of General Medical Sciences awarded Duke University $375,996 on July 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop protein language model innovations for sequence design and functional prediction. The award funds three representation-learning advances addressing limitations in current protein language models. Aim 1 creates length-invariant generative representations that systematically explore insertions, deletions, and...
- Federal Grant Award Summary The University of New Mexico Health Sciences Center received a $2,094,250 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2029. This research project investigates the intersection between the methionine cycle and coronavirus RNA capping mechanisms, with the primary objective of identifying novel drug targets to inhibit...
- The National Institute of General Medical Sciences awarded the University of New Mexico Health Sciences Center $419,375 on April 1, 2026, to investigate the systemic effects of metabolic enzyme dysfunctions under the Biomedical Research and Research Training program (CFDA 93.859). The recipient will conduct research examining how dysfunctions in D-2-hydroxyglutarate (2HG) metabolism cascade through interconnected biochemical pathways to produce systemic disease. 2HG is an intermediary in...
- The National Institute of General Medical Sciences awarded New York University $185,462 on August 10, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop machine learning schemes that predict rare biomolecular events using short molecular dynamics trajectories rather than computationally prohibitive long simulations. The research addresses the challenge of characterizing infrequent biological phenomena—such as insulin dimer dissociation, which can require...
- This Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $448,723 to Brigham Young University to develop AI and physics-based models to predict protein mutations that enhance the stability and function of therapeutic and diagnostic proteins. The key products and services to be delivered include rapid design-build-test-learn cycles that integrate AI tools with cell-free protein synthesis and...
- The National Institute of General Medical Sciences awarded Albert Einstein College of Medicine $361,200 on August 15, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop computational methods for predicting and simulating interactions between cell surface proteins with multiple domains in the immunoglobulin fold. The project addresses a fundamental challenge in structural biology: current experimental methods cannot reliably measure transient interactions...
- The National Institute of General Medical Sciences, part of the Department of Health and Human Services National Institutes of Health, awarded Southern Methodist University $447,174 on June 1, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to support computational research on protein dynamics and chemical kinetics using generative artificial intelligence and advanced theoretical modeling. The research focuses on three major themes: protein allostery mechanisms,...
The National Institute of General Medical Sciences awarded the University of New Mexico Health Sciences Center $419,375 on August 25, 2026, under the Biomedical Research and Research Training program (CFDA 93.859) to develop two artificial intelligence models—Protein2Hypothesis and ProteinChem2Hypothesis—that translate protein and chemical sequences into human-readable functional descriptions and mechanistic explanations of protein function. Project 1 will transform an existing Protein2Text model into Protein2Hypothesis, which predicts protein function, explains reasoning through mechanistic rationales, provides calibrated uncertainty estimates, and interprets the impact of coding variants including insertions, deletions, and frameshifts. This project will also produce DICE, a novel framework for instruction-guided protein design. Project 2 will develop ProteinChem2Hypothesis, a machine learning model that predicts interactions between protein and chemical representations. The team will leverage Azure cloud credits and compute allocations on the Frontier supercomputer at Oak Ridge National Laboratory to train large models and process massive datasets. The work addresses a gap created by the existence of 227 million known proteins and 111 million chemical compounds whose variants and interactions are too numerous to explore experimentally. Performance occurs in Albuquerque, New Mexico. The period of performance runs through July 31, 2031.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $419.4k | 8/25/26 |